Bellerophon Therapeutics

+$0.24 (+5.87%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell BLPH and other stocks, options, and ETFs commission-free!

About BLPH

Bellerophon Therapeutics, Inc. focuses on developing products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline include PH-ILD, PH-COPD and PH-Sarc.

CEO
Fabian Tenenbaum
Employees
21
Headquarters
Warren, New Jersey
Founded
2009

BLPH Key Statistics

Market Cap
40.01M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
44.01K
High Today
$4.60
Low Today
$4.08
Open Price
$4.12
Volume
75.69K
52 Week High
$17.22
52 Week Low
$3.79

BLPH Earnings

-$1.08
-$0.72
-$0.36
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.69 per share
Actual
-$0.58 per share

You May Also Like

EEMV
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure